Both in Pharmaceuticals
Tyra Biosciences vs Innoviva
Over the past year TYRA returned +49.4% and INVA returned +19.4%; their daily moves had a correlation of 0.13.
TYRA +49.4% INVA +19.4%Growth of $1, one year, split-adjusted
| Metric | TYRA | INVA |
|---|---|---|
| Price | $21.75 | $21.12 |
| Market cap | $1.50B | $1.53B |
| Today | +1.07% | +0.86% |
| 1 month | −1.0% | 0.0% |
| 6 months | −35.6% | −8.4% |
| Year to date | −17.3% | +5.7% |
| 1 year | +46.6% | +19.2% |
| Revenue growth (YoY) | — | +19.3% |
| Gross margin | — | 81.3% |
| Net margin | — | −69.8% |
| P/E (TTM) | — | 4.3× |
| Price / sales | — | 3.5× |
| Net cash | $353.9M | $319.0M |
| Dividend yield | — | — |
| Volatility (60d) | 88.8% | 22.6% |
| Short % of float | 26.5% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).